CASE REPORT
Limbic encephalitis – a report of four cases
 
More details
Hide details
 
Submission date: 2016-02-08
 
 
Final revision date: 2016-05-18
 
 
Acceptance date: 2016-05-23
 
 
Publication date: 2017-08-08
 
 
Cent Eur J Immunol 2017;42(2):213-217
 
KEYWORDS
ABSTRACT
Usually limbic encephalitis (LE) is a paraneoplastic neurologic syndrome. LE symptoms can precede cancer even by a few years. Almost 50% of LE cases are connected with small cell lung carcinoma. Testis and breast cancers, granulomatous disease, thymoma, and teratomas are also often connected with LE. Other cases have infectious and autoimmunological aetiology. In LE limbic system dysfunction is observed, and it is accompanied by cerebellum and brain stem abnormalities as well as polyneuropathy. Paraneoplastic limbic encephalitis is sometimes a part of larger syndrome in which brain stem and spinal cord are involved in an inflammatory process called paraneoplastic encephalomyelitis. The main LE symptoms are: impairment of cognitive functions with subacute beginning, partial and generalised seizures, mental distress, disturbances of consciousness, and limb paresis. In MRI study hyperintensive lesions in the medial part of the temporal lobes in T2 and FLAIR sequences are present. Sharp and slow waves in electroencephalography in the temporal area are also frequent. In cerebrospinal fluid pleocytosis, elevation of protein level, intensification of immunoglobulin synthesis, and oligoclonal bands can be detected. The majority of patients with paraneoplastic LE have onconeural antibodies in the blood. The presented study is a description of the clinical course of the disease in four patients diagnosed with LE.
REFERENCES (27)
1.
Brierley J, Corsellis J, Hierons R, et al. (1960): Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 83: 357-368.
 
2.
Corsellis J, Goldberg G, Norton A (1968): “Limbic encephalitis” and its association with carcinoma. Brain 91: 481-496.
 
3.
Dalmau J, Rosenfeld M (2008): Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340.
 
4.
Gultekin S, Rosenfeld M, Voltz R, et al. (2000): Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumor association in 50 patients. Brain 123: 1481-1494.
 
5.
Anderson N, Rosenblum M, Graus F, et al. (1988): Autoantibodies in paraneoplastic syndromes associated with small -cell lung cancer. Neurology 38: 1391-1398.
 
6.
Dalmau J, Furneaux H, Rosenblum M, et al. (1991): Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/ sensory neuronopathy. Neurology 41: 1757-1764.
 
7.
Posner J, Paraneoplastic syndromes. Neurologic complications of cancer, 1995;353-385.
 
8.
Graus F, Cordon Cardo C, Posner J (1985): Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538-543.
 
9.
Jubelt B, Cashman N (1987): Neurological manifestations of the post-polio syndrome. Crit Rev Neurobiol 3: 199-220.
 
10.
Buckley C, Oger J, Clover L, et al. (2001): Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50: 74-79.
 
11.
Vincent A, Buckley C, Schott J, et al. (2004): Potassium channel antibody-associated encephalopathy: a potentially immunotherapy responsive form of limbic encephalitis. Brain 127: 701-712.
 
12.
Thieben M, Lennon V, Boeve B, et al. (2004): Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62: 1177-1182.
 
13.
Saiz A, Blanco Y, Sabater L, et al. (2008): Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131: 2553-2563.
 
14.
Mata S, Muscas G, Naldi I, et al. (2008): Non -paraneoplastic limbic encephalitis associated with anti- glutamic acid decarboxylase antibodies. J Neuroimmunol 199: 155-159.
 
15.
Ances B, Vitaliani R, Taylor R, et al. (2005): Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128: 1764-1777.
 
16.
Dalmau J., Tuzun E., Wu H, et al. (2007): Paraneoplastic anti -N -methyl -D -aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36.
 
17.
Ramlow J, Alexander M, LaPorte R, et al. (1992): Epidemiology of the post-polio syndrome. Am J Epidemiol 136: 769-786.
 
18.
Gołąb-Janowska M, Nowacki P (2011): Limbic encephalitis: a review of literature. Ann Acad Med Stet 57: 5-11.
 
19.
Asaoka K, Shoji H., Nishizaka S, et al. (2004): Non herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Intern Med 43: 42-48.
 
20.
Bodian D (1947): Poliomyelitis: Neuropathologic observations in relation to motor symptoms. J Am Med Assoc 134: 1148-1154.
 
21.
Zuliani L, Saiz A, Tavolato B, et al. (2007): Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti -glial nuclear antibodies in identifying the tumour. J Neurol Neurosurg Psychiatry 78: 204-205.
 
22.
Tuzun E, Dalmau J (2007): Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13: 261-271.
 
23.
Daly D, Markand O (1990): Focal brain lesions. Curr Pract Clin Electroencephalography 335-370.
 
24.
Lawn N, Westmoreland B, Kiely M, et al. (2003): Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clinic Proceedings 78: 1363-1368.
 
25.
Nowacki P (2008): Neuropatologic basis of paraneoplastic syndromes. Pol Rev Neurol 4: 168-174.
 
26.
Brierley J, Corsellis J, Hierons R, et al. (1960): Subacute encephalitis of later adult life, mainly affecting the limbic areas. Brain 83: 357-368.
 
27.
Alamowitch, F, Graus M, Uchuya R, et al. (1997): Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120: 923-928.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top